Related Experiment Video

Updated: May 3, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.0K

Smac mimetics and innate immune stimuli synergize to promote tumor death

Shawn T Beug1, Vera A Tang1, Eric C LaCasse1

  • 1Solange Gauthier Karsh Molecular Genetics Laboratory, Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Nature Biotechnology
|January 28, 2014
PubMed

Insights

Smac mimetic compounds combined with oncolytic viruses and adjuvants show promise in cancer treatment. This combination induces a "cytokine storm" for enhanced anti-tumor effects, leading to tumor regression and improved survival in mice.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Smac mimetic compounds (SMC) sensitize cancer cells to apoptosis by inhibiting IAP proteins.
  • SMC monotherapy efficacy is limited to tumors producing high levels of death-inducing proteins.
  • Synergistic strategies are needed to broaden SMC therapeutic potential.

Purpose of the Study:

  • To investigate the synergistic effects of SMCs with agents inducing a "cytokine storm."
  • To evaluate the potential of combining SMCs with oncolytic viruses and adjuvants (poly(I:C), CpG).
  • To determine the mechanisms underlying the observed synergistic anti-cancer activity.

Main Methods:

  • Treatment of cancer cells with SMCs in combination with oncolytic viruses and adjuvants.
  • Assessment of bystander cell death mediated by cytokines like IFN-β, TNF-α, and TRAIL.
  • Evaluation of tumor regression and survival in preclinical cancer models.

Main Results:

  • Oncolytic viruses and adjuvants induced bystander cancer cell death when combined with SMCs.
  • This synergistic effect was mediated by key inflammatory cytokines.
  • Combinatorial treatment led to significant tumor regression and extended survival in mouse models.

Conclusions:

  • Combining Smac mimetic compounds with oncolytic viruses and adjuvants represents a promising therapeutic strategy.
  • The induction of a cytokine storm is a key mechanism for enhanced anti-cancer efficacy.
  • Further clinical investigation of this combination therapy is warranted for cancer treatment.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.4K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

7.9K

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K